Arcophos, Inc.
StreetZero Signal 61
About Arcophos, Inc.
Arcophos is the frontier research lab for AI-native healthcare systems. It runs controlled experiments in clinical deployment environments to measurably improve SOTA model performance in long-horizon, non-verifiable healthcare domains. The company aims to address the critical shortage of doctors and nurses by ushering in the era of autonomous healthcare through AI-native facilities built for recursive intelligence.
LATEST FUNDINGPrivate Placement
$1.3M
Announced 2026-11-10
TOTAL RAISED$1,282,500
IN THE NEWS
- ๐ Arcophos
- ๐ 5 Interesting Startup Deals You May Have Missed In December: A Hospital-Grade Wireless Heart Monitor, AI-Designed Proteins For Manufacturing, And More
- ๐ Healthcare Innovation: Atropos Health Gets Series A Funding, Names CEO - Atropos Health
- ๐ Insights: 5 Health Technology Companies Raise $700M+ ...
- ๐ MKS Technology Inc. - 2026 Funding Rounds & List of Investors - Tracxn
EMPLOYEESโ
FOUNDEDโ
HQSan Francisco, CA, United States
Industry
Other Technology
Tags
AIHealthcareResearch
Investors
Not disclosed in the source filing. Form D filings do not list investors โ StreetZero surfaces them from news where available.
Key highlights
- Operates as a frontier research lab focused on AI-native healthcare systems.
- Conducts experiments in clinical deployment environments to advance model performance.
- Targets autonomous healthcare facilities to address doctor and nurse shortages.
- Raised $1.2825M via private placement with undisclosed investors.
Ask StreetZero about Arcophos, Inc.
Put our AI to work on this deal.
Similar companies
Other Other Technology deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account